What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice.

CME information and select publications here